Clinical Trials Browser

Phase 2 × ficlatuzumab × Clear all

NCT03422536 2024-09-04

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Lip Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT02318368 2020-10-22

FOCAL

Phase 2 Terminated

10 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04100330 2020-03-31

CyFi2

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute